Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-06-06 11:59 am Purchase |
2025-05-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
JANUS HENDERSON GROUP PLC JHG |
5,081,957 10.300% |
306,582![]() (+6.42%) |
Filing History |
2025-05-15 3:32 pm Sale |
2025-03-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
JANUS HENDERSON GROUP PLC JHG |
4,775,375 9.700% |
-223,402![]() (-4.47%) |
Filing History |
2025-05-14 11:59 am Purchase |
2025-03-31 | 13G | Mereo BioPharma Group plc MREO |
JANUS HENDERSON GROUP PLC JHG |
22,735,121 14.300% |
5,612,558![]() (+32.78%) |
Filing History |
2025-05-07 10:57 am Purchase |
2025-04-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
JANUS HENDERSON GROUP PLC JHG |
4,998,777 10.100% |
417,135![]() (+9.10%) |
Filing History |
2025-02-14 12:11 pm Purchase |
2024-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
JANUS HENDERSON GROUP PLC JHG |
4,581,642 9.500% |
101,358![]() (+2.26%) |
Filing History |
2025-02-14 12:09 pm Purchase |
2024-12-31 | 13G | Mereo BioPharma Group plc MREO |
JANUS HENDERSON GROUP PLC JHG |
17,122,563 11.000% |
17,122,563![]() (New Position) |
Filing History |
2025-02-14 12:06 pm Sale |
2024-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 2,606,938 5.430% |
-838,425![]() (-24.33%) |
Filing History |
2025-02-14 12:01 pm Purchase |
2024-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Eventide Asset Management, LLC | 2,220,000 3.460% |
2,220,000![]() (New Position) |
Filing History |
2024-11-14 4:37 pm Sale |
2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BIOTECHNOLOGY VALUE FUND L P | 3,075,907 6.400% |
-1,294,117![]() (-29.61%) |
Filing History |
2024-11-14 12:55 pm Sale |
2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
JANUS HENDERSON GROUP PLC JHG |
4,480,284 9.400% |
-508,463![]() (-10.19%) |
Filing History |
2024-11-14 12:25 pm Purchase |
2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 3,445,363 7.220% |
751,782![]() (+27.91%) |
Filing History |
2024-11-12 11:44 am Purchase |
2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BlackRock Inc. BLK |
3,406,072 7.100% |
37,915![]() (+1.13%) |
Filing History |
2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BlackRock Inc. BLK |
3,368,157 7.100% |
835,515![]() (+32.99%) |
Filing History |
2024-07-10 1:12 pm Purchase |
2024-06-28 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
JANUS HENDERSON GROUP PLC JHG |
4,988,747 10.600% |
4,988,747![]() (New Position) |
Filing History |
2024-02-14 12:49 pm Purchase |
2023-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 2,693,581 5.780% |
636,581![]() (+30.95%) |
Filing History |
2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
The Vanguard Group | 2,476,244 5.310% |
2,476,244![]() (New Position) |
Filing History |
2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BlackRock Inc. BLK |
2,532,642 5.400% |
854,735![]() (+50.94%) |
Filing History |
2023-12-29 4:01 pm Sale |
2023-12-21 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
New Enterprise Associates 16, L.P. | 0 0.000% |
-2,186,243![]() (Position Closed) |
Filing History |
2023-09-18 4:35 pm Purchase |
2023-09-07 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BIOTECHNOLOGY VALUE FUND L P | 4,370,024 9.400% |
4,370,024![]() (New Position) |
Filing History |
2023-09-05 3:11 pm Purchase |
2023-08-31 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 6,226,392 13.400% |
1,815,285![]() (+41.15%) |
Filing History |